Literature DB >> 9300351

Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs.

T C Krejcie1, J A Jacquez, M J Avram, C U Niemann, C A Shanks, T K Henthorn.   

Abstract

The gamma and Erlang density functions describe a large class of lagged, right-skewed distributions. The Erlang distribution has been shown to be the analytic solution for a chain of compartments with identical rate constants. This relationship makes it useful for the analysis of first-pass pulmonary drug uptake data following intravenous bolus administration and the incorporation of this analysis into an overall systemic drug disposition model. However, others have shown that one Erlang density function characterizes the residence time distribution of solutes in single tissues with significant systematic error. We propose a model of two Erlang density functions in parallel that does characterize well the arterial appearance of indocyanine green, antipyrine, and alfentanil administered simultaneously by right atrial bolus injection. We derive the equations that permit calculation of the higher order moments of a system consisting of two parallel Erlang density functions and use the results of these calculations from the data for all three indicators to estimate pulmonary capillary blood volume and mean transit time in the dog.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9300351     DOI: 10.1007/BF02353481

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  24 in total

1.  Effects of blood flow on diffusion kinetics in isolated, perfused hindlegs of cats; a double circulation hypothesis.

Authors:  E M RENKIN
Journal:  Am J Physiol       Date:  1955-10

2.  An assessment of methods for sampling blood to characterize rapidly changing blood drug concentrations.

Authors:  Y F Huang; R N Upton; L E Mather; W B Runciman
Journal:  J Pharm Sci       Date:  1991-09       Impact factor: 3.534

3.  Influence of physicochemical parameters and perfusate flow rate on the distribution of solutes in the isolated perfused rat hindlimb determined by the impulse-response technique.

Authors:  Z Y Wu; S E Cross; M S Roberts
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

4.  Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

Authors:  M S Roberts; J D Donaldson; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

5.  Impact of parallel heterogeneity on a continuum model of the pulmonary arterial tree.

Authors:  G S Krenz; J Lin; C A Dawson; J H Linehan
Journal:  J Appl Physiol (1985)       Date:  1994-08

6.  Minimal compartmental model of circulatory mixing of indocyanine green.

Authors:  T K Henthorn; M J Avram; T C Krejcie; C A Shanks; A Asada; D A Kaczynski
Journal:  Am J Physiol       Date:  1992-03

7.  Pulmonary capillary transport function from flow-limited indicators.

Authors:  S H Audi; G S Krenz; J H Linehan; D A Rickaby; C A Dawson
Journal:  J Appl Physiol (1985)       Date:  1994-07

8.  A recirculatory pharmacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs.

Authors:  T C Krejcie; T K Henthorn; C A Shanks; M J Avram
Journal:  J Pharmacol Exp Ther       Date:  1994-05       Impact factor: 4.030

9.  Erythrocyte transit and neutrophil concentration in the dog lung.

Authors:  J C Hogg; T McLean; B A Martin; B Wiggs
Journal:  J Appl Physiol (1985)       Date:  1988-09

10.  Comparison of direct and indirect measurements of pulmonary capillary transit times.

Authors:  R L Capen; L P Latham; W W Wagner
Journal:  J Appl Physiol (1985)       Date:  1987-03
View more
  6 in total

1.  Application of a gamma model of absorption to oral cyclosporin.

Authors:  J Debord; E Risco; M Harel; Y Le Meur; M Büchler; G Lachâtre; C Le Guellec; P Marquet
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

3.  A recirculatory model of the pulmonary uptake and pharmacokinetics of lidocaine based on analysis of arterial and mixed venous data from dogs.

Authors:  T C Krejcie; M J Avram; W B Gentry; C U Niemann; M P Janowski; T K Henthorn
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

4.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

Review 5.  Population pharmacokinetics of cyclosporine in transplant recipients.

Authors:  Kelong Han; Venkateswaran C Pillai; Raman Venkataramanan
Journal:  AAPS J       Date:  2013-06-18       Impact factor: 4.009

6.  A Novel Method for Studying the Pharmacokinetics of [(14) C]Umeclidinium After Application to the Axilla or Palm of Healthy Male Subjects.

Authors:  T Pene Dumitrescu; L L Santos; S C Hughes; A I Pereira; G C Young; E Hussey; P Charlton; S Baptiste-Brown; J S Stuart; V Vincent; S P van Marle; V D Schmith
Journal:  Clin Transl Sci       Date:  2016-06-15       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.